We identified CD3+CD4+CXCR5+ TFH cells in the CSF by flow cytometry and found a significantly increased proportion of TFH cells in MS patients (Fig. 4a, b) in accordance with previous studies in the blood48 and CSF49. The gene discussed is CD4; the disease is myeloid sarcoma.